Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2017, Article ID 3410820, 15 pages
https://doi.org/10.1155/2017/3410820
Review Article

Comparison of Globus Pallidus Interna and Subthalamic Nucleus in Deep Brain Stimulation for Parkinson Disease: An Institutional Experience and Review

1Department of Neurology and Neurotherapeutics, UT Southwestern, Dallas, TX, USA
2Department of Neurology and Neurotherapeutics, Section of Movement Disorders, UT Southwestern, Dallas, TX, USA
3UT Southwestern Medical School, Dallas, TX, USA
4Henry Ford Hospital, Detroit, MI, USA
5Emory University, Atlanta, GA, USA

Correspondence should be addressed to Shilpa Chitnis; ude.nretsewhtuostu@sintihc.aplihs

Received 2 March 2017; Accepted 7 May 2017; Published 19 June 2017

Academic Editor: Aparna Wagle Shukla

Copyright © 2017 Shazia Mirza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Wagle Shukla and M. S. Okun, “Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches,” Neurotherapeutics, vol. 11, no. 1, pp. 47–59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Pollak, A. L. Benabid, C. Gross et al., “Effects of the stimulation of the subthalamic nucleus in Parkinson disease,” Revue Neurologique, vol. 149, no. 3, pp. 175-176, 1993. View at Google Scholar
  3. A. L. Benabid, P. Pollak, A. Louveau, S. Henry, and J. de Rougemont, “Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease,” Appl Neurophysiol, vol. 50, no. 1-6, pp. 344–346, 1987. View at Google Scholar
  4. P. L. Gildenberg, “Evolution of neuromodulation,” Stereotactic and Functional Neurosurgery, vol. 83, no. 2-3, pp. 71–79, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. W. Langston, P. Ballard, J. W. Tetrud, and I. Irwin, “Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis,” Science, vol. 219, no. 4587, pp. 979-980, 1983. View at Google Scholar
  6. R. S. Burns, C. C. Chiueh, S. P. Markey, M. H. Ebert, D. M. Jacobowitz, and I. J. Kopin, “A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 14, pp. 4546–4550, 1983. View at Publisher · View at Google Scholar · View at Scopus
  7. I. J. Mitchell, A. Jackson, M. A. Sambrook, and A. R. Crossman, “The role of the subthalamic nucleus in experimental chorea: Evidence FROM 2-deoxyglucose METABOLIC mapping AND horseradish PEROXIDASE tracing studies,” Brain, vol. 112, no. 6, pp. 1533–1548, 1989. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Bergman, T. Wichmann, and M. R. DeLong, “Reversal of experimental Parkinsonism by lesions of the subthalamic nucleus,” Science, vol. 249, no. 4975, pp. 1436–1438, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Z. Aziz, D. Peggs, M. A. Sambrook, and A. R. Crossman, “Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate,” Movement Disorders, vol. 6, no. 4, pp. 288–292, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Deuschl, C. Schade-Brittinger, P. Krack et al., “A randomized trial of deep-brain stimulation for Parkinson's disease,” The New England Journal of Medicine, vol. 355, no. 9, pp. 896–908, 2006. View at Google Scholar
  11. F. M. Weaver, K. Follett, M. Stern et al., “Bilateral deep brain stimulation vs best medical therapy for patients with advanced parkinson disease: a randomized controlled trial,” JAMA-Journal of the American Medical Association, vol. 301, no. 1, pp. 63–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. B. Dewey, P. E. O'Suilleabhain, M. Sanghera et al., “Developing a deep brain stimulation neuromodulationnetwork for Parkinson disease, essential tremor, and dystonia: Report of a quality improvement project,” PLoS ONE, vol. 11, no. 10, Article ID e0164154, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Krack, P. Pollak, P. Limousin, A. Benazzouz, and A. L. Benabid, “Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease,” Lancet, vol. 350, no. 9092, p. 1675, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Limousin, P. Pollak, A. Benazzouz et al., “Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation,” The Lancet, vol. 345, no. 8942, pp. 91–95, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Obeso, C. W. Olanow, M. C. Rodriguez-Oroz, P. Krack, R. Kumar, and A. E. Lang, “Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease,” New England Journal of Medicine, vol. 345, no. 13, pp. 956–963, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. K. A. Follett et al., “Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease,” N Engl J Med, vol. 362, no. 22, pp. 2077–2091, 2010. View at Google Scholar
  17. F. M. Weaver et al., “Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes,” Neurology, vol. 79, no. 1, pp. 55–65, 2012. View at Google Scholar
  18. V. C. Anderson, K. J. Burchiel, P. Hogarth, J. Favre, and J. P. Hammerstad, “Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease,” Archives of Neurology, vol. 62, no. 4, pp. 554–560, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. S. Okun and K. D. Foote, “Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: Will pallidal deep brain stimulation make a triumphant return?” Archives of Neurology, vol. 62, no. 4, pp. 533–536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. N. R. Williams, K. D. Foote, and M. S. Okun, “Subthalamic nucleus versus globus pallidus internus deep brain stimulation: translating the rematch into clinical practice,” Movement Disorders Clinical Practice, vol. 1, no. 1, pp. 24–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Fukaya and T. Yamamoto, “Deep brain stimulation for Parkinson’s disease: Recent trends and future direction,” Neurologia Medico-Chirurgica, vol. 55, no. 5, pp. 422–431, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. V. J. Odekerken, J. A. Boel, B. A. Schmand et al., “GPi vs STN deep brain stimulation for parkinson disease: three-year follow-up,” Neurology, vol. 86, no. 8, pp. 755–761, 2016. View at Google Scholar
  23. V. J. Odekerken, T. van Laar, M. J. Staal et al., “Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial,” Lancet Neurol, vol. 12, no. 1, pp. 37–44, 2013. View at Publisher · View at Google Scholar
  24. Y. Liu, W. Li, C. Tan et al., “Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease,” Journal of Neurosurgery, vol. 121, no. 3, pp. 709–718, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Weaver, K. Follett, K. Hur, D. Ippolito, and M. Stern, “Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes,” Journal of Neurosurgery, vol. 103, no. 6, pp. 956–967, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. S. Okun et al., Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial, vol. 65, no. 5, pp. 586–595, 2009.
  27. P. Blomstedt, U. Sandvik, and S. Tisch, “Deep brain stimulation in the posterior subthalamic area in the treatment of essential tremor,” Movement Disorders, vol. 25, no. 10, pp. 1350–1356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Patel, P. Khemani, M. Sanghera, I. Podkorytova, L. A. Whitworth, and S. Chitnis, “Dual pallidal and subthalamic stimulation in medication intolerant Parkinson disease,” UTSW.
  29. R. J. Cook, L. Jones, G. Fracchia et al., “Globus pallidus internus deep brain stimulation as rescue therapy for refractory dyskinesias following effective subthalamic nucleus stimulation,” Stereotactic and Functional Neurosurgery, vol. 93, no. 1, pp. 25–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. C. M. Matias, D. Silva, A. G. Machado, and S. E. Cooper, “"Rescue" of bilateral subthalamic stimulation by bilateral pallidal stimulation: case report,” Journal of neurosurgery, vol. 124, no. 2, pp. 417–421, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Krack, P. Pollak, P. Limousin et al., “Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease,” Brain, vol. 121, no. 3, pp. 451–457, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Sriram, “Brittle Dyskinesia Following STN but not GPi Deep Brain Stimulation,” Tremor Other Hyperkinet Mov (N Y, vol. 4, p. 242, 2014. View at Google Scholar
  33. P. Limousin, P. Krack, P. Pollak et al., “Electrical stimulation of the subthalamic nucleus in advanced Parkinsonian's disease,” New England Journal of Medicine, vol. 339, no. 16, pp. 1105–1111, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Krack, A. Batir, N. van Blercom et al., “Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” The New England Journal of Medicine, vol. 349, no. 20, pp. 1925–1934, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. Hely, W. G. J. Reid, M. A. Adena, G. M. Halliday, and J. G. L. Morris, “The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years,” Movement Disorders, vol. 23, no. 6, pp. 837–844, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Bang Henriksen, E. L. Johnsen, N. Sunde, A. Vase, M. C. Gjelstrup, and K. Østergaard, “Surviving 10 years with deep brain stimulation for Parkinson's disease - a follow-up of 79 patients,” European Journal of Neurology, vol. 23, no. 1, pp. 53–61, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. H. L. Combs, B. S. Folley, D. T. R. Berry et al., “Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in parkinson’s disease: a meta-analysis,” Neuropsychology Review, vol. 25, no. 4, pp. 439–454, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. M. S. Okun, B. V. Gallo, and G. Mandybur, “Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial,” Lancet Neurol, vol. 11, no. 2, pp. 140–149, 2012. View at Publisher · View at Google Scholar
  39. A. E. Williams, G. M. Arzola, A. M. Strutt, R. Simpson, J. Jankovic, and M. K. York, “Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation,” Parkinsonism and Related Disorders, vol. 17, no. 5, pp. 321–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Aybek, A. Gronchi-Perrin, A. Berney et al., “Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease,” Movement Disorders, vol. 22, no. 7, pp. 974–981, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. H. M. M. Smeding, P. Van Den Munckhof, R. A. J. Esselink, B. Schmand, P. R. Schuurman, and J. D. Speelman, “Reversible cognitive decline after DBS STN in PD and displacement of electrodes,” Neurology, vol. 68, no. 15, pp. 1235-1236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Rektorova, Z. Hummelova, and M. Balaz, “Dementia after DBS surgery: A case report and literature review,” Parkinson's Disease, Article ID 679283, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Miocinovic, J. Jordan, L. Lacritz, P. Khemani, and S. Chitnis, “Role of electrode location in the development of cognitive impairment following bilateral STN DBS surgery,” UT Southwestern Medical Center.
  44. J. L. Houeto, V. Mesnage, L. Mallet et al., “Behavioural disorders, Parkinson's disease and subthalamic stimulation,” Journal of Neurology Neurosurgery and Psychiatry, vol. 72, no. 6, pp. 701–707, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Amami, I. Dekker, S. Piacentini et al., “Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, no. 5, pp. 562–564, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Weintraub, J. E. Duda, K. Carlson et al., “Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: Results from a randomised, controlled trial,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 10, pp. 1113–1118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Maier, C. J. Lewis, N. Horstkoetter et al., “Subjective perceived outcome of subthalamic deep brain stimulation in Parkinson's disease one year after surgery,” Parkinsonism and Related Disorders, vol. 24, pp. 41–47, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. L. B. Zahodne, M. S. Okun, K. D. Foote et al., “Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus,” Journal of Neurology, vol. 256, no. 8, pp. 1321–1329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Ngoga, R. Mitchell, J. Kausar, J. Hodson, A. Harries, and H. Pall, “Deep brain stimulation improves survival in severe Parkinson's disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 85, no. 1, pp. 17–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Maier, C. J. Lewis, C. Eggers et al., “Development and validation of the deep brain stimulation impairment scale (DBS-IS),” Parkinsonism & Related Disorders, vol. 36, pp. 69–75, 2017. View at Publisher · View at Google Scholar
  51. A. M. Lozano and B. J. Snyder, “Deep brain stimulation for parkinsonian gait disorders,” Journal of Neurology, vol. 255, no. 4, pp. 30-31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. M. S. Troche, A. E. Brandimore, K. D. Foote, and M. S. Okun, “Swallowing and deep brain stimulation in Parkinson's disease: a systematic review,” Parkinsonism and Related Disorders, vol. 19, no. 9, pp. 783–788, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Skodda, “Effect of deep brain stimulation on speech performance in Parkinson's disease,” Parkinson's Disease, vol. 2012, Article ID 850596, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Eugster, P. Bargiotas, C. L. Bassetti, and W. M. Michael Schuepbach, “Deep brain stimulation and sleep-wake functions in Parkinson's disease: a systematic review,” Parkinsonism and Related Disorders, vol. 32, pp. 12–19, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. C. E. Clarke, “Has drug therapy changed the natural history of Parkinson's disease?” Journal of Neurology, vol. 257, Suppl 2, pp. S262–S267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. W. M. Schuepbach, J. Rau, K. Knudsen et al., “Neurostimulation for Parkinson's disease with early motor complications,” The New England Journal of Medicine, vol. 368, no. 7, pp. 610–622, 2013. View at Google Scholar
  57. R. J. St. George, J. G. Nutt, K. J. Burchiel, and F. B. Horak, “A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD,” Neurology, vol. 75, no. 14, pp. 1292–1299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Tagliati, “Turning tables: Should GPi become the preferred DBS target for Parkinson disease?” Neurology, vol. 79, no. 1, pp. 19-20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. H. A. Taba, S. S. Wu, K. D. Foote et al., “A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort,” Journal of Neurosurgery, vol. 113, no. 6, pp. 1224–1229, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Sidiropoulos and P. A. Lewitt, “GPi vs STN deep brain stimulation for Parkinson disease: three-year follow-up,” Neurology, vol. 87, no. 7, pp. 745-746, 2016. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Witt, O. Granert, C. Daniels et al., “Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial,” Brain, vol. 136, no. 7, pp. 2109–2119, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. J. L. Houeto, P. B. Bejjani, P. Damier et al., “Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD,” Neurology, vol. 55, no. 5, pp. 728–730, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. R. L. Jacob, J. Geddes, S. McCartney, and K. J. Burchiel, “Cost analysis of awake versus asleep deep brain stimulation: A single academic health center experience,” Journal of Neurosurgery, vol. 124, no. 5, pp. 1517–1523, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. J. B. Pietzsch, A. M. Garner, and W. J. Marks, “Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States,” Neuromodulation, vol. 19, no. 7, pp. 689–697, 2016. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Eggington, F. Valldeoriola, K. R. Chaudhuri, K. Ashkan, E. Annoni, and G. Deuschl, “The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease,” Journal of Neurology, vol. 261, no. 1, pp. 106–116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. M. L. Hacker, A. D. Currie, A. L. Molinari et al., “Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease,” Journal of Parkinson's Disease, vol. 6, no. 1, pp. 125–131, 2016. View at Publisher · View at Google Scholar · View at Scopus
  67. M. L. Hacker, J. Tonascia, M. Turchan et al., “Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease,” Parkinsonism & Related Disorders, vol. 21, no. 10, pp. 1177–1183, 2015. View at Publisher · View at Google Scholar
  68. M. S. Okun, J. Green, R. Saben, R. Gross, K. D. Foote, and J. L. Vitek, “Mood changes with deep brain stimulation of STN and GPi: results of a pilot study,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 74, no. 11, pp. 1584–1586, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. Z. Mirzadeh, K. Chapple, M. Lambert et al., “Parkinson's disease outcomes after intraoperative CT-guided asleep deep brain stimulation in the globus pallidus internus,” Journal of Neurosurgery, vol. 124, no. 4, pp. 902–907, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Chen, Z. Mirzadeh, K. Chapple, M. Lambert, and F. A. Ponce, “Complication rates, lengths of stay, and readmission rates in "awake" and "asleep" deep brain simulation,” Journal of Neurosurgery, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  71. A. L. Ho, R. Ali, I. D. Connolly et al., “Awake versus asleep deep brain stimulation for Parkinson's disease: a critical comparison and meta-analysis,” Journal of Neurology, Neurosurgery & Psychiatry, p. jnnp-2016-314500, 2017. View at Publisher · View at Google Scholar
  72. K. A. Follett and D. Torres-Russotto, “Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson's disease: Which target?” Parkinsonism and Related Disorders, vol. 18, Supplment 1, no. 1, pp. S165–S167, 2012. View at Google Scholar · View at Scopus
  73. D. Weiss, M. Walach, C. Meisner et al., “Nigral stimulation for resistant axial motor impairment in Parkinson's disease? A randomized controlled trial,” Brain, vol. 136, no. 7, pp. 2098–2108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Peppe, A. Gasbarra, A. Stefani et al., “Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease?” Parkinsonism and Related Disorders, vol. 14, no. 6, pp. 501–504, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. N. R. Williams, T. R. Hopkins, E. B. Short et al., “Reward circuit DBS improves Parkinson’s gait along with severe depression and OCD,” Neurocase, vol. 22, no. 2, pp. 201–204, 2016. View at Publisher · View at Google Scholar · View at Scopus